| Role of nanotechnology in targeted drug delivery and imaging: a concise review OM Koo, I Rubinstein, H Onyuksel Nanomedicine: nanotechnology, biology and medicine 1 (3), 193-212, 2005 | 985 | 2005 |
| Improvement of drug safety by the use of lipid-based nanocarriers SB Lim, A Banerjee, H Önyüksel Journal of controlled release 163 (1), 34-45, 2012 | 335 | 2012 |
| In vitro characterization of PEGylated phospholipid micelles for improved drug solubilization: effects of PEG chain length and PC incorporation B Ashok, L Arleth, RP Hjelm, I Rubinstein, H Önyüksel Journal of pharmaceutical sciences 93 (10), 2476-2487, 2004 | 289 | 2004 |
| In vivo targeting of acoustically reflective liposomes for intravascular and transvascular ultrasonic enhancement SM Demos, H Alkan-Onyuksel, BJ Kane, K Ramani, A Nagaraj, R Greene, ... Journal of the American College of Cardiology 33 (3), 867-875, 1999 | 274 | 1999 |
| A mixed micellar formulation suitable for the parenteral administration of taxol H Alkan-Onyuksel, S Ramakrishnan, HB Chai, JM Pezzuto Pharmaceutical research 11, 206-212, 1994 | 248 | 1994 |
| Development of inherently echogenic liposomes as an ultrasonic contrast agent H Alkan-Onyuksel, SM Demos, GM Lanza, MJ Vonesh, ME Klegerman, ... Journal of pharmaceutical sciences 85 (5), 486-490, 1996 | 228 | 1996 |
| Sterically Stabilized Phospholipid Mixed Micelles: In Vitro Evaluation as a Novel Carrier for Water-Insoluble Drugs A Krishnadas, I Rubinstein, H Önyüksel Pharmaceutical research 20, 297-302, 2003 | 206 | 2003 |
| Organization of phosphatidylcholine and bile salt in rodlike mixed micelles RP Hjelm Jr, P Thiyagarajan, H Alkan-Onyuksel The Journal of Physical Chemistry 96 (21), 8653-8661, 1992 | 175 | 1992 |
| VIP grafted sterically stabilized liposomes for targeted imaging of breast cancer: in vivo studies S Dagar, A Krishnadas, I Rubinstein, MJ Blend, H Önyüksel Journal of Controlled Release 91 (1-2), 123-133, 2003 | 172 | 2003 |
| Materials and methods for making improved micelle compositions H Önyüksel, I Rubinstein US Patent 6,217,886, 2001 | 147 | 2001 |
| Camptothecin in sterically stabilized phospholipid micelles: a novel nanomedicine OM Koo, I Rubinstein, H Onyuksel Nanomedicine: Nanotechnology, Biology and Medicine 1 (1), 77-84, 2005 | 136 | 2005 |
| Structure and dynamics of highly PEG-ylated sterically stabilized micelles in aqueous media L Vukovic, FA Khatib, SP Drake, A Madriaga, KS Brandenburg, P Král, ... Journal of the American Chemical Society 133 (34), 13481-13488, 2011 | 123 | 2011 |
| Mechanistic studies on surfactant-induced membrane permeability enhancement WJ Xia, H Onyuksel Pharmaceutical research 17, 612-618, 2000 | 123 | 2000 |
| Actively targeted low-dose camptothecin as a safe, long-acting, disease-modifying nanomedicine for rheumatoid arthritis OMY Koo, I Rubinstein, H Önyüksel Pharmaceutical research 28, 776-787, 2011 | 112 | 2011 |
| PEGylated phospholipid nanomicelles interact with β-amyloid (1–42) and mitigate its β-sheet formation, aggregation and neurotoxicity in vitro AS Pai, I Rubinstein, H Önyüksel Peptides 27 (11), 2858-2866, 2006 | 102 | 2006 |
| Use of cyclodextrins as a cosmetic delivery system for fragrance materials: Linalool and benzyl acetate U Numanoğlu, T Şen, N Tarimci, M Kartal, OMY Koo, H Önyüksel Aaps Pharmscitech 8, 34-42, 2007 | 99 | 2007 |
| Nanomicellar paclitaxel increases cytotoxicity of multidrug resistant breast cancer cells H Önyüksel, E Jeon, I Rubinstein Cancer letters 274 (2), 327-330, 2009 | 89 | 2009 |
| Detailed structure of hairy mixed micelles formed by phosphatidylcholine and PEGylated phospholipids in aqueous media L Arleth, B Ashok, H Onyuksel, P Thiyagarajan, J Jacob, RP Hjelm Langmuir 21 (8), 3279-3290, 2005 | 84 | 2005 |
| Acoustically reflective liposomes and methods to make and use same GM Lanza, MH Onyuksel, ME Klegerman, MJ Vonesh, DL McPherson US Patent 5,612,057, 1997 | 82 | 1997 |
| VIP receptors as molecular targets of breast cancer: implications for targeted imaging and drug delivery S Dagar, M Sekosan, BS Lee, I Rubinstein, H Önyüksel Journal of Controlled Release 74 (1-3), 129-134, 2001 | 81 | 2001 |
